JP2010536786A - ポリカチオンを用いた抗体およびfc融合分子の製剤 - Google Patents
ポリカチオンを用いた抗体およびfc融合分子の製剤 Download PDFInfo
- Publication number
- JP2010536786A JP2010536786A JP2010521190A JP2010521190A JP2010536786A JP 2010536786 A JP2010536786 A JP 2010536786A JP 2010521190 A JP2010521190 A JP 2010521190A JP 2010521190 A JP2010521190 A JP 2010521190A JP 2010536786 A JP2010536786 A JP 2010536786A
- Authority
- JP
- Japan
- Prior art keywords
- polycation
- antibody
- formulation
- composition
- mab
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95651407P | 2007-08-17 | 2007-08-17 | |
PCT/US2008/073250 WO2009026122A1 (fr) | 2007-08-17 | 2008-08-15 | Formulations d'anticorps et de molécules de fusion fc à l'aide de polycations |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2010536786A true JP2010536786A (ja) | 2010-12-02 |
Family
ID=40014979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010521190A Withdrawn JP2010536786A (ja) | 2007-08-17 | 2008-08-15 | ポリカチオンを用いた抗体およびfc融合分子の製剤 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2190476A1 (fr) |
JP (1) | JP2010536786A (fr) |
AU (1) | AU2008289225A1 (fr) |
CA (1) | CA2696049A1 (fr) |
MX (1) | MX2010001723A (fr) |
WO (1) | WO2009026122A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883979B2 (en) | 2012-08-31 | 2014-11-11 | Bayer Healthcare Llc | Anti-prolactin receptor antibody formulations |
WO2015064591A1 (fr) | 2013-10-28 | 2015-05-07 | テルモ株式会社 | Suspension aqueuse de protéine |
JP2015532657A (ja) * | 2012-09-05 | 2015-11-12 | トラコン ファーマシューティカルズ、インコーポレイテッド | 抗体製剤及びその使用 |
US9944714B2 (en) | 2009-09-30 | 2018-04-17 | Tracon Pharmaceuticals, Inc. | Endoglin antibodies |
WO2019022094A1 (fr) * | 2017-07-24 | 2019-01-31 | テルモ株式会社 | Procédé de production d'un complexe contenant une protéine médicale et un acide polyaminé, et complexe contenant une protéine médicale et un acide polyaminé |
JP2020138981A (ja) * | 2017-03-01 | 2020-09-03 | メドイミューン・リミテッドMedImmune Limited | モノクローナル抗体製剤 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767206B2 (en) | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
CN102821787B (zh) | 2010-01-15 | 2015-07-29 | 麒麟-安姆根有限公司 | 抗体制剂和治疗方案 |
CN102585016B (zh) * | 2012-03-06 | 2014-06-04 | 江苏健德生物药业有限公司 | 一种可同时抑制t、b淋巴细胞功能的免疫融合蛋白、其制备方法及其应用 |
CN103232542B (zh) * | 2013-02-01 | 2015-05-13 | 殷勇 | 一种双靶标嵌合蛋白 |
CN110496099B (zh) | 2013-09-11 | 2022-06-21 | 伊戈尔生物药品股份有限公司 | 包含粘度降低剂的液体蛋白质制剂 |
MX2017004306A (es) | 2014-10-01 | 2017-12-20 | Eagle Biologics Inc | Formulaciones de polisacáridos y ácido nucleico que contienen agentes de reducción de viscosidad. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8904370D0 (en) * | 1989-02-25 | 1989-04-12 | Cosmas Damian Ltd | Liquid delivery compositions |
AU653771B2 (en) * | 1991-01-03 | 1994-10-13 | Alkermes Controlled Therapeutics, Inc. | Stabilization of proteins by cationic biopolymers |
DE4110409C2 (de) * | 1991-03-29 | 1999-05-27 | Boehringer Ingelheim Int | Neue Protein-Polykation-Konjugate |
US5521291A (en) * | 1991-09-30 | 1996-05-28 | Boehringer Ingelheim International, Gmbh | Conjugates for introducing nucleic acid into higher eucaryotic cells |
GB9320782D0 (en) * | 1993-10-08 | 1993-12-01 | Univ Leeds Innovations Ltd | Stabilising of proteins on solution |
US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
-
2008
- 2008-08-15 CA CA2696049A patent/CA2696049A1/fr not_active Abandoned
- 2008-08-15 WO PCT/US2008/073250 patent/WO2009026122A1/fr active Application Filing
- 2008-08-15 EP EP08827865A patent/EP2190476A1/fr not_active Withdrawn
- 2008-08-15 JP JP2010521190A patent/JP2010536786A/ja not_active Withdrawn
- 2008-08-15 AU AU2008289225A patent/AU2008289225A1/en not_active Abandoned
- 2008-08-15 MX MX2010001723A patent/MX2010001723A/es not_active Application Discontinuation
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9944714B2 (en) | 2009-09-30 | 2018-04-17 | Tracon Pharmaceuticals, Inc. | Endoglin antibodies |
US8883979B2 (en) | 2012-08-31 | 2014-11-11 | Bayer Healthcare Llc | Anti-prolactin receptor antibody formulations |
JP2015532657A (ja) * | 2012-09-05 | 2015-11-12 | トラコン ファーマシューティカルズ、インコーポレイテッド | 抗体製剤及びその使用 |
JP2018076350A (ja) * | 2012-09-05 | 2018-05-17 | トラコン ファーマシューティカルズ、インコーポレイテッド | 抗体製剤及びその使用 |
US10195281B2 (en) | 2012-09-05 | 2019-02-05 | Tracon Pharmaceuticals, Inc. | Antibody formulations and uses thereof |
JP2019059753A (ja) * | 2012-09-05 | 2019-04-18 | トラコン ファーマシューティカルズ、インコーポレイテッド | 抗体製剤及びその使用 |
WO2015064591A1 (fr) | 2013-10-28 | 2015-05-07 | テルモ株式会社 | Suspension aqueuse de protéine |
JP2019043955A (ja) * | 2013-10-28 | 2019-03-22 | テルモ株式会社 | タンパク質水性懸濁剤 |
JP2020138981A (ja) * | 2017-03-01 | 2020-09-03 | メドイミューン・リミテッドMedImmune Limited | モノクローナル抗体製剤 |
WO2019022094A1 (fr) * | 2017-07-24 | 2019-01-31 | テルモ株式会社 | Procédé de production d'un complexe contenant une protéine médicale et un acide polyaminé, et complexe contenant une protéine médicale et un acide polyaminé |
JP2019023175A (ja) * | 2017-07-24 | 2019-02-14 | テルモ株式会社 | 医療用タンパク質とポリアミノ酸とを含む複合体の製造方法および医療用タンパク質とポリアミノ酸とを含む複合体 |
JP7104929B2 (ja) | 2017-07-24 | 2022-07-22 | テルモ株式会社 | 医療用タンパク質とポリアミノ酸とを含む複合体の製造方法および医療用タンパク質とポリアミノ酸とを含む複合体 |
Also Published As
Publication number | Publication date |
---|---|
CA2696049A1 (fr) | 2009-02-26 |
EP2190476A1 (fr) | 2010-06-02 |
AU2008289225A1 (en) | 2009-02-26 |
WO2009026122A1 (fr) | 2009-02-26 |
MX2010001723A (es) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010536786A (ja) | ポリカチオンを用いた抗体およびfc融合分子の製剤 | |
JP6416336B2 (ja) | 高濃度抗体製剤 | |
JP6416841B2 (ja) | 医薬製剤 | |
CN1886158B (zh) | 包含抗egf受体抗体的药物制剂 | |
ES2882135T3 (es) | Formulaciones estabilizadas que contienen anticuerpos anti-NGF | |
ES2750254T3 (es) | Formulaciones farmacéuticas | |
CA2966646A1 (fr) | Methodes de traitement de maladies oculaires | |
CN107206070B (zh) | 降低药物制剂的粘度 | |
EP3681483B1 (fr) | Procédé de formulation pharmaceutique lyophilisée d'une protéine thérapeutique | |
US10568951B2 (en) | Pharmaceutical composition of an anti-VEGF antibody | |
EA031436B1 (ru) | Водная фармацевтическая композиция, содержащий ее предварительно заполненный шприц и применение композиции в лечении аутоиммунных заболеваний | |
JP2022105056A (ja) | 高濃度の抗vegf抗体を含有するタンパク質溶液製剤 | |
JP2018531980A (ja) | 抗d因子抗体製剤 | |
EA043419B1 (ru) | Способ получения лиофилизированного фармацевтического состава на основе терапевтического белка |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20111101 |